EX-10.1 2 d700036dex101.htm JOINDER AND SEVENTH LOAN MODIFICATION AGREEMENT JOINDER AND SEVENTH LOAN MODIFICATION AGREEMENTLoan Modification Agreement • May 5th, 2020
Contract Type FiledMay 5th, 2020This Joinder and Seventh Loan Modification Agreement (this “Loan Modification Agreement”) is entered into and effective as of April 30, 2014 (the “Seventh Loan Modification Effective Date”), by and between (i) SILICON VALLEY BANK, a California corporation, with its principal place of business at 3003 Tasman Drive, Santa Clara, California 95054 and with a loan production office located at 380 Interlocken Crescent, Suite 600, Broomfield, Colorado 80021 (“Bank”), (ii) ATRICURE, INC., a Delaware corporation with its chief executive office located at 6217 Centre Park Drive, West Chester, Ohio 45069 (“Atricure”), (iii) ATRICURE, LLC, a Delaware limited liability company (“Atricure LLC”, and together with Atricure, individually and collectively, jointly and severally, the “Borrower”) and (iv) ENDOSCOPIC TECHNOLOGIES, LLC, a Delaware limited liability company (the “New Borrower”).
JOINDER AND SEVENTH LOAN MODIFICATION AGREEMENTLoan Modification Agreement • April 30th, 2014 • AtriCure, Inc. • Surgical & medical instruments & apparatus
Contract Type FiledApril 30th, 2014 Company IndustryThis Joinder and Seventh Loan Modification Agreement (this “Loan Modification Agreement”) is entered into and effective as of April 30, 2014 (the “Seventh Loan Modification Effective Date”), by and between (i) SILICON VALLEY BANK, a California corporation, with its principal place of business at 3003 Tasman Drive, Santa Clara, California 95054 and with a loan production office located at 380 Interlocken Crescent, Suite 600, Broomfield, Colorado 80021 (“Bank”), (ii) ATRICURE, INC., a Delaware corporation with its chief executive office located at 6217 Centre Park Drive, West Chester, Ohio 45069 (“Atricure”), (iii) ATRICURE, LLC, a Delaware limited liability company (“Atricure LLC”, and together with Atricure, individually and collectively, jointly and severally, the “Borrower”) and (iv) ENDOSCOPIC TECHNOLOGIES, LLC, a Delaware limited liability company (the “New Borrower”).